The upcoming release of Chapter <86> to the United States Pharmacopeia will open the door for non-animal-derived reagents in endotoxin testing, including innovative methods utilizing recombinant cascade (rCR) and recombinant Factor C (rFC) reagents. This workshop will explore the integration of these sustainable methods with the Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform.
Through a comprehensive case study comparing traditional Limulus Amebocyte Lysate (LAL) reagents with their non-animal counterparts, the workshop will demonstrate the efficacy and reliability of these alternative reagents across a diverse range of pharmaceutical products. Real-world samples will be analyzed to provide valuable insights into testing methodologies and the practical benefits of adopting non-animal-derived reagents.
Attendees will gain practical knowledge on how to implement rCR technology in their endotoxin testing protocols, paving the way for more ethical and sustainable practices in pharmaceutical quality control while ensuring compliance with USP <86> guidelines.
This workshop is ideal for professionals involved in pharmaceutical quality control, laboratory managers, regulatory affairs specialists, and anyone involved in endotoxin testing. It is particularly beneficial for those seeking to stay ahead of regulatory changes and implement non-animal-derived reagents in endotoxin testing. Attendees will gain valuable insights into new methodologies, technology integration, and sustainable practices in endotoxin testing.
This workshop covers the following topics:
Gain a comprehensive understanding of the upcoming changes to USP <86> and how they open the door for non-animal-derived reagents in endotoxin testing.
Master rCR and rFC TechnologyLearn the application of recombinant cascade (rCR) and recombinant Factor C (rFC) reagents in endotoxin testing, understanding their advantages over traditional LAL reagents.
Evaluate the Efficacy of rCR TechnologyUnderstand how rCR technology performs across a diverse range of pharmaceutical products and how it compares to traditional endotoxin testing methods in terms of reliability and accuracy.
Implement rCR Technology in Testing ProtocolsGain practical insights into integrating rCR technology with the Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform and adapting testing protocols for compliance with USP <86> guidelines.
All participants will receive a certificate of attendance upon completion of the workshop.Note: Registration closes one week prior to the start of workshop.
Veolia Water Technologies & Solutions
Product Manager - Sievers bio-detection instruments